CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

Date Issued
2020
Author(s)
Chen, Linfeng
Ouyang, Jing
Wienand, Kirsty
Bojarczuk, Kamil
Hao, Yansheng
Neuberg, Donna
Juszczynski, Przemyslaw
Lawton, Lee N.
Rodig, Scott J.
Monti, Stefano
Shipp, Margaret A.
DOI
10.3324/haematol.2019.216218